Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy.
J Exp Clin Cancer Res. 2022 Oct 21;41(1):309. doi: 10.1186/s13046-022-02479-y.
J Exp Clin Cancer Res. 2022.
PMID: 36271379
Free PMC article.
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers.
Martinelli I, Modica C, Chiriaco C, Basilico C, Hughes JM, Corso S, Giordano S, Comoglio PM, Vigna E.
Martinelli I, et al.
J Exp Clin Cancer Res. 2022 Mar 29;41(1):112. doi: 10.1186/s13046-022-02320-6.
J Exp Clin Cancer Res. 2022.
PMID: 35351166
Free PMC article.
Item in Clipboard
Cite
Cite